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Monocyte recruitment in cryoglobulinemic membranoproliferative gb-
merubonephritis: A pathogenetic role for monocyte chemotactic peptide-1.
Monocyte chemotactic pcptide-1 (MCP-1) belongs to a large family of
cytokines known as chemokines. It is a potent mediator of inflammatory
response and is thought to play a major role in recruiting monocytes into
the site of inflammation. Mixed cryoglobulinemia is a systemic vasculitis
characterized in 20 to 30% of the eases by renal involvement. Monocyte
infiltration into the glomerulus, and in the periglomerular and perivascu-
lar areas is a common histopathological feature of this form of glomeru-
lonephritis. We sought to determine, by in situ hybridization and immu-
nohistochemistry, the renal gene and protein expression of MCP-1 in
cryoglobulinemie glomerulonephritis compared to normal kidney, and to
correlate it with macrophage infiltration. Kidney biopsy specimens were
obtained from 9 patients with cryoglobulinemic glomerulonephritis and 9
control kidneys. The distribution and intensity of MCP-1 gene and protein
expression, and the macrophage infiltration (CD68 positive cells) were
evaluated and quantitated by a computerized image analysis system. In
normal kidneys, MCP-1 was weakly expressed, both at the gene as well as
at the protein level. In diseased kidneys, a statistically significant (P <
0.001) up-regulation of MCP-1 gene and protein expression was found,
particularly within the areas of tuhulointerstitial damage and the glomer-
nh. By means of CD68 positive cells, a significant correlation (P < 0.001)
was found between glomerular, tubulointerstitial macrophage infiltration
and MCP-1 expression. Moreover, by combining immunohistochemistry
and in situ hybridization, we observed the presence of CD68 positive cells
mainly, if not exclusively, around the cells expressing MCP-l mRNA.
Interestingly, a striking increase in MCP-1 urinary concentration was
found in cryoglohulinemic patients. In conclusion, our data suggest that
MCP-1 may play a major role in modulating the inflammatory process
observed in cryoglobulinemic glomerulonephritis.
Mixed eryoglobulinemia is a systemic vasculitis characterized in
20 to 30% of the cases by renal involvement [I]. The classical renal
lesion is a membranoproliferative glomerulonephritis (GN) with
fibrillar glomerular deposits and intracapillary hyalin thrombi,
mainly constituted by aggregated cryoglobulins [fl. Monocyte—
maerophage infiltration into the glomerulus, the periglomerular
and perivascular areas is a common histopathological feature of
this form of glomerular disease [1—41. There is relatively little
knowledge of the mechanisms by which infiltrating cells enter the
normal or inflamed glomerulus. A number of chemoattractants
have recently been identified [5]. These proteins are grouped into
the small eytokine/intercrine/Scy superfamily, based upon similar-
ities in sequence and genomic structures [5]. These include
platelet factor-4, CINC, TP-10 and monocyte chemotactic pep-
tide-i (MCP-1) [5]. MCP-1 is a potent and specific ehemotactic
and activating factor for monoeytes, and is thought to play a major
role in recruiting these cells into the site of inflammation [5, 61.
Indeed, an increased expression of MCP-1 has already been
reported in vivo in several diseases associated with a monoeyte
infiltrate, such as atherosclerosis, rheumatoid arthritis and idio-
pathic pulmonary fibrosis [7—10]. Endothelial cells, vascular
smooth muscle cells, mesangial cells, cortical tubular epithelial
cells and macrophages have been shown to produce this chemoat-
tractant [11—17]. Several stimuli, such as cytokines (that is,
interleukin-1 and tumor necrosis factor-alpha) and LDL can
induce MCP-1 production by mesangial cells [11—121. Moreover,
Hora et al demonstrated that IgG aggregates, by Fc-y-R occu-
pancy, induce MCP-1 mRNA expression and the release of its
protein in cultured mouse mesangial cells [17]. Therefore, it is
conceivable that cryoglobulins, deposited at the mesangial and
tubular level in eryoglobulinemic membranoproliferative GN,
may stimulate mesangial as well as tubular cells to produce
MCP-1, which are finally responsible for the recruitment of
monocytes into the glomerulus and interstitial space.
Recently, Rovin et al demonstrated by immunohistochemistry
the in vivo expression of MCP-1 in experimental and human GN
[18]. They found MCP-1 protein in glomeruli from patients with
glomerulopathies different from membranoproliferative GN, but
were unable to identify the cellular source of MCP-1. In the
present study, we attempt to better address the possible patho-
physiological role played by MCP-1 in cryoglohulinemic mem-
branoproliferative GN and investigate, by in situ hybridization
coupled with immunohistochemistry techniques, its renal gene
and protein expression, as well as its urinary concentration.
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Patients
Nine patients with type II mixed cryoglobulinemia and biopsy-
proven membranoproliferative GN were enrolled into the study
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Table 1. Clinical findings at the time of renal biopsy and after therapy (mean follow up, 6 months from renal biopsy) in 9 patients with IgMk-lgG
mixed cryoglobulinemia and membranoproliferative GN
Patients Sex/age Hypertension Hematuria
Pre-treatment
Upr,,t g/day Sr Therapy"
Post-treatment
Upr0t g/day Scr
1. BA
2. CG
3. CD
4. DLV
5. EG
6. LVU
7MG
8. SA
9. SV
F/71
M/44
F/50
M/70
M/75
M/58
M/65
F/57
M/62
No
No
Yes
Yes
No
Yes
No
No
No
2+
4+
4+
2+
2+
4+
2+
4+
4+
1.2
5.2
2.5
6.8
5.5
8.2
1.8
3.2
3.0
0.9
1.5
1.2
3.2
1.4
3.0
1.8
1.0
2.0
C, I
C, 1
C
C, 1
C, A
C, A
C
C, I
C
L
2.0
0.8
2.2
0.2
1.3
L
1.6
1.1
L
1.2
1.1
1.6
1.2
2.9
L
1.0
1.5
Abbreviations are: 1, immunosuppressor; C, corticosteroids; A, ACE inhibitors; L, lost at the follow-up.
after giving their informed consent (Table 1). Apparently normal
cortical portions obtained from patients undergoing nephrectomy
for renal carcinoma, strictly matched for sex and age, were used as
control kidneys.
Renal biopsies were performed with a semi-automatic Colt
needle (Sterilab, Milan, Italy). Two cortical fragments were
obtained from each patient. Immunofluorescence and light mi-
croscopy were performed routinely to establish the histologic
diagnosis. A portion of the cortical fragment was used for in situ
hybridization and immunohistochemistry.
In situ hybridization
Renal tissue was immediately included in OCT compound,
snap-frozen in liquid nitrogen and stored in the same liquid until
used. Frozen sections (6 jim thick) were collected onto polylysine-
coated slides, dried briefly on a hot plate at + 80°C and fixed in 4%
paraformaldehyde for 20 minutes. After two washes in PBS,
dehydration in graded ethanol and short air drying, sections were
immediately used for in situ hybridization.
For the synthesis of the MCP-1 RNA probe, we used a 200 bp
human MCP-1 eDNA fragment as the template. This fragment
was obtained by RT-PCR of total RNA extracted from cultured
human mesangial cells, using two specific primers (sense primer,
5 '1TCTGTGCCTGCTGCTCA3'; antisense primer, 5 'CTCACT-
CACAAGTTCAGA3') deducted from the human full length
eDNA sequence. The resultant PCR product was subcloned into
the PCRII vector (In Vitrogen Corp., San Diego, CA, USA) and
sequenced. After linearization of the plasmid with either BamHI
or XbaI restriction endonucleases, T7 or SP6 RNA-polymerases
(Boehringer Mannheim, Germany), respectively, were employed
to obtain run off transcripts of either the antisense (complemen-
tary to mRNA) or sense (negative control) strands. Transcription
and labeling of RNA probes was performed as previously de-
scribed [19]. Briefly, 80 jiCi of [35S]uridine-5'-(a-thio)-triphos-
phate (S.A.; 1,250 Ci/mmol; Amersham, Little Chalfont, UK) was
added to a 10 j.d reaction mixture (0.5 m each of adenosine-,
cytosine- and guanosine-5'-triphosphate!l mvt dithiothreitol/10
units human placental RNase inhibitor/6 m MgCl2/10 mrvt Tris-
HC1, pH 7.5/2 mivt spermidine/lO mi NaC1) including 1 jig of
linearized plasmid and 16 units of either SP6 or T7 RNA
polymerase. The mixture was then incubated for 60 minutes at
38°C. The template DNA was removed by digestion with 25 jsg/ml
RNase-free DNase I in the appropriate buffer containing 2.5
mg/mI of yeast tRNA and 10 units of RNase inhibitor for 10
minutes at 37°C. Free ribonucleotides were removed by phenol-
chloroform extraction and ethanol precipitation. RNA probes
were then diluted in hybridization buffer, stored at —80°C and
used within four weeks. The specific activity usually obtained was
1.2 to 1.4 x iO cpm/mg of 35S-labeled RNA probe.
Prehybridization, hybridization, removal of nonspecifically
bound probe by RNase A digestion, and further washing proce-
dures were performed for both sense and antisense MCP-1 RNA
probe as previously described [19].
Autoradiography was performed by dipping the dehydrated
slides into Ilford G5 nuclear emulsion (Ilford, Mobberley
Cheshire, UK). The exposed slides were developed using Kodak
D19 developer (Kodak, Hemel Hampstead, UK), counter-stained
in hematoxylin and, finally, mounted.
Immunohistochemistiy
The immunohistochemical detection of monocytes was per-
formed on frozen 4 jim-thick biopsy sections using chromato-
graphically purified mouse anti-CD68 monoclonal antibody, spe-
cific for human monocytes (Clone EBM11; Dako, Milan, Italy).
For immunohistochemical detection of the MCP-1 protein, a
specific rabbit polyclonal anti-baboon MCP-1 antibody, crossre-
acting with the human peptide (a gift of Dr. A.J. Valente,
University of Texas at San Antonio) was used [7, 10]. Immobilized
mouse and rabbit antibodies were detected by the immunoalka-
line phosphatase (APAAP) method with affinity-purified rabbit
anti-mouse and mouse anti-rabbit immunoglobulin serum (Dako)
and APAAP complex (1:50 dilution; Dako), following a two and
three step technique, respectively, as previously described [19].
Alkaline phosphatase was developed with New Fuchsin (Sigma,
Milan, Italy). Negative controls were performed by omitting the
primary or secondary antibodies, and employing non-immune
mouse or rabbit antiserum as first layer.
Immunohistochemistiy coupled to in situ hybridization
This technique was performed to detect simultaneously CD68
positive cells by immunohistochemistry, and cells expressing
MCP-1, by in situ hybridization on the same biopsy section. Six
micron-thick renal sections were first fixed in 4% paraformalde-
hyde, and thus sequentially treated for immunohistochemistry and
in situ hybridization as reported above.
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Microscopy studies
Computer morphometry (Optilab Pro 2.6.1 Softaware, Image
Analysis System; Graftek, Villanterio, Pavia, Italy) was used to
quantify the CD68 positive cells and the optical density of the
signals generated by silver grains (in situ hybridization). The video
image was generated by a video camera (Hamamatsu, Milan,
Italy) connected to a Leica microscope (Lcitz DMRBE, Wetzlar,
Germany) and to a Power PC computer (Macintosh, Cupertino,
CA, USA) equipped with a frame grabber (Hamamatsu). Single
images were digitized for image analysis at 256 gray levels. An
optical threshold and filter combination was set to select only the
nuclei of the CD68 positive cells or the silver grains (in situ
hybridization: MCP-1 mRNA).
Number of interstitial and glomerular CD68+ cells and number
of pixels generated by silver grains were quantified in five to eight
randomly selected areas from each biopsy. The regions of interest
were interactively discriminated by the operators using the cursor
and then automatically measured for total area. Each parameter
was calculated by analyzing two serial sections and overlaying the
two images obtained. The resulting counts divided by the inter-
stitial and glomerular total area gave the measures desired.
Urinaiy McP-1 assay
Quantitative determination of the MCP-1 protein concentra-
tion in the nine-hour urine collection of 8 cryoglobulinemic
patients and of 8 healthy volunteers was performed using a human
MCP-1 ELISA kit (Quantikine; R&D, Abingdon, UK). This is a
multiple sandwich solid-phase enzyme immunoassay that uses
monoclonal antibodies raised against human MCP-1. The sensi-
tivity of the ELISA is 5 pg/ml. The mean recovery of recombinant
human MCP-l spiked in human urine was 92% (range 85 to
100%). The enzymatic reaction was detected in an automatic
microplate photometer (Titertek; Flow Labs, USA). The MCP-1
concentration of the unknown samples was determined by inter-
polation into a standard curve developed with known amounts of
recombinant human MCP-1 protein. Urine MCP-l protein levels
were normalized to urine creatinine and expressed as pg/mg urine
creatinine.
Cell isolation and culture
Human mesangial cells (HMC) were established and charac-
terized as reported previously [20]. Cells were allowed to grow
until confluent in RPMI 1640 medium (Gibco Laboratories,
Grand Island, NY, USA) supplemented with 17% heat-inacti-
vated fetal bovine serum (FBS; Hyclone Laboratories, Inc., Lo-
gan, UT, USA), 100 U/mI penicillin, 100 mg/mI streptomycin, 2
mM L-glutamine, 2 m sodium pyruvate, 1% (vol/vol) non-
essential amino acids, 5 jtg/ml insulin, 5 g/ml transferrin and 5
ng/ml selenium. For passage, confluent cells were washed with
PBS, removed with 0.025% trypsin/0.5 mivi EDTA in PBS and
plated in RPM!. Experiments included in this study were per-
formed on cells between the fifth and tenth passages.
RNA isolation and Northern blot analysis
For each experiment, 2 X 106 cells were plated and cultured as
detailed above. After reaching confluency, HMC were kept for 48
hours in serum-free medium and then incubated for six hours with
100 jig/mI of either human aggregated IgG or cryoglobulins. At
the end of incubation, cells were lysed with 4 M guanidium
isothiocyanate containing 25 m sodium citrate, pH 7.0, 0.5%
sarcosyl and 0.1 mrvi 2--mercaptoethanol. Total RNA was iso-
lated by the single-step method, using phenol and chloroform/
isoamylalcohol [201. Electrophoresis of 20 jig of total RNA was
carried out in 1% agarose gel with 2.2 M formaldehyde. The RNA
was then transferred overnight to a nylon membrane (Schleicher
& Schuell, Dassel, Germany). The cDNA probe used was a 0.7 kb
fragment encoding the Baboon MCP-1. The cDNA was labeled
with (32P) dCTP (3,000 Ci/mmol; Amershani, UK) by random
primer extension and added at 1 X 106 cpm/ml. Prehybridization
and hybridization were performed for 18 hours at 42°C in a buffer
containing 50% formamide, 5 X SSC, 5 X Denhart's solution,
0.1% SDS, 100 mg/mI denatured salmon sperm DNA. The blots
were then washed once in 2 x SSC, 0.1% SDS at 22°C for five
minutes, and once in the same buffer at 55°C for 30 minutes.
Finally, the membranes were washed in I X SSC, 0.1% SDS at
55°C for further 30 minutes. After drying, membranes were
exposed to a Kodak X-OMAT film with intensifying screens at
—70°C.
Statistical analysis
Quantitative data were compared among the groups by the
unpaired Student's t-test. The correlation coefficients are Pear-
son's r values.
Results
Table 1 summarizes the main clinical findings of the 9 patients
with cryoglohulinemic membranoproliferative GN at the time of
renal biopsy and after 6 to 8 weeks of treatment. All patients had
proteinuria and in 4 of them the urinary protein loss was in the
nephrotic range (> 3.5 g/day). By immunohistochemistry, using
the CD68 antigen as a marker, an intense macrophage infiltration
was observed in cryoglobulinemic GN in glomeruli (Fig. I A, B),
in periglomerular (Fig. IB) and perivascular (Fig. IC) areas. Few
macrophages were observed in normal appearing portions of
human kidney removed for renal carcinoma (data not shown).
Moreover, compared to normal kidney (Fig. 2 A, B), diseased
kidneys (Fig. 2 C-F) showed a statistically significant (P < 0.001)
up-regulation of MCP-1 gene expression. The expression was
mainly localized in the area of tubulointerstitial damage (Fig. 2 C,
D) and into the glomeruli (Fig. 2 E, F). By combining in situ
hybridization and immunohistochemistry, we observed that mono-
cytes preferentially localize next to the cells expressing MCP-1
(Fig. 3). The mRNA for MCP-1 was expressed by parietal
epithelial cells, tubular cells and both CD68 positive and CD68
negative cells in the glomerulus (Fig. 3). Interestingly, the cells
lining tubules occupied by hyaline casts presented a striking
increase in MCP-1 gene expression (data not shown). A significant
correlation (P < 0.001) was found between glomerular and
interstitial monocyte infiltration and MCP-I gene expression. No
hybridization was seen with the corresponding sense probe or with
RNase treatment (data not shown). MCP-1 protein expression, as
evaluated by immunohistochemistry and using a specific poly-
clonal anti-baboon MCP-1 antibody, was absent in normal renal
tissue (data not shown) and clearly increased in cryoglobulinemic
GN, with a pattern similar to tnat observed for mRNA expression
(Fig. 4 A, B). In addition, to evaluate if the increased tissue
expression of MCP-1 determined an increase in urinary excretion
of this chemokine, we studied the urinary level of MCP-1 in 8
normal subjects and in 8 cryoglobulinemic patients. Interestingly,
a
, 
—
'3
 
-
 
I;.
 
-
 
Jc
_b
lt 
t, 
158 Gesualdo et al: MCP-1 in ctyoglobulinemic ON
Fig. 1. Immunohistochemisoy fbr 0J68 antigen of kidney biopsy specimens from patients with ciyoglobulinemic membranoprolifrrative GN. A. Section
stained with the murinc anti-CD68 antibody demonstrating the presence of monocytes-macrophages in a glomerulus (X200; j' indicates a
representative CD 68 positive cell). B. CD68 positive cells disrupt the Bowman's capsule (>< 200; ). C. Sections demonstrating a diffuse perivascular
infiltrate positive for CD-68 antigen (X200; indicates the vessel). D. Negative control obtained using a non-immune mouse serum (X100).
the urinary concentration of MCP-1 protein was strikingly in-
creased in patients with ciyoglobulinemic membranoproliferative
GN compared to normal subjects (4691 1891 vs. 36 18 pg/mg
urine creatinine, P < 0.001). All patients were treated with
corticosteroids and some of them in association with immunosup-
pressor agents or ACE inhibitors. As reported in Table 1,
treatment was able to reduce the amount of daily proteinuria and
serum creatinine levels. Unfortunately, post-treatment urine sam-
ples were not available. Finally, in order to evaluate a direct effect
of cryoglobulins on renal cells in inducing MCP-1 mRNA expres-
sion, cultured HMC were stimulated with either heat-aggregated
IgG or cryoglobulins isolated from a patient with cryoglobuline-
mic membranoproliferative GN. As shown in Figure 5, aggregated
lgG and cryoglobulins induced MCP-1 gene expression in HMC
with the same intensity.
Discussion
In the present study we demonstrate, for the first time, that
MCP-1 is expressed both at the gene and protein level in vivo
during cryoglobulinemic membranoproliferative GN. Although
monocyte infiltration is a common histopathological feature of
several primary and secondary glomerulonephritides, the mecha-
nisms involved in monocyte recruiment in renal tissue are still
debated. MCP-1 is a chemokine with a highly specific chemotactic
effect on monocytes [6]. In addition to this well known action,
MCP-1 may also activate these cells, as demonstrated by the
increase in cytosolic free calcium, the induction of respiratory
burst and the release of cytokines [21, 22]. These features make
this chemokine one of the most likely candidates in the patho-
genesis of monocyte influx and activation in renal diseases [231.
Moreover, several investigators have described in vivo expression
of MCP-1 in other diseases characterized by monocyte infiltration
such as atherosclerosis, rheumatoid arthritis and idiopathic pul-
monary fibrosis [7—10]. The strong correlation found between
MCP-1 expression and monocyte/macrophage infiltration sup-
ports the hypothesis that MCP-1 may play an important role in the
recruitment of these cells during this specific inflammatory pro-
cess. This chemokine is produced in vitro by mesangial, endothe-
hal and proximal tubular cells, and its production is induced by
different cytokines as well as by IgG aggregates [11—171. In
cryoglobulinemic GN, immune complexes constituted by cryo-
globulins are known to deposit into the glomerulus, at the
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Fig. 2. In situ hybridization for MCP-1. Dark (A, x200) and bright (B, x200) field photomicrographs of normal appearing portions of human kidney
removed for renal carcinoma not expressing MCP-1 mRNA. Dark (C and E) and bright (D and F) field photomicrographs of sections from biopsies
of patients affected by cryoglobulinemic membranoproliferative GN demonstrating a marked increase in MCP-1 message, mainly localized within the
tubular cells and the interstitial infiltrate (C and D, X100; 1) and a positive signal within the glomerular area (E and F, X100; 1').
mesangial level, along the tubular basement membranes, and in
the dilated tubuli occupied by the hyalin casts [1]. Interestingly,
MCP-1-producing cells were localized in the glomerulus and at
the tubulointerstitial level mainly in the proximity of cryoglobulin
deposits. In the glomerulus as well as in the tubulointerstitial
compartment, MCP-1 mRNA was localized within both CD68
negative and CD68 positive cells. Unfortunately, while tubular
and parietal epithelial cells were easily identified, we were unable
to characterize the CD68 negative cells expressing MCP-1 at the
glomerular level, since a good mesangial cells marker is lacking.
However, since cryoglobulins were able, in vitro, to induce MCP-1
expression in human mesangial cells, we can hypothesize that
intraglomerular CD 68 negative cells may be of mesangial origin.
In the present study, the expression of this chemokine was
localized both at the glomerular as well as at the tubulointerstitial
level. On the contrary, Prodjosudiadi et al have reported that
MCP-1 was expressed primarily at the tubulointerstitial level in
different glomerular diseases [241. Indeed, this same pattern of
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Fig. 3. Immunohistochemisty for CD68 coupled with in situ hybridization for MCP-J. A. CD68 positive cells within the glomerulus expressing MCP-1
mRNA (X400; 't). B. MCP-1 mRNA positive cells within the mesangial area not expressing CD68 (x200; t). C. A glomerulus with CD68 negative
cells expressing MCP-1 mRNA (x200; 1') and showing a periglomerular CD68 positive cells infiltrate (1' 1). D. Glomerular parietal epithelial cells
expressing MCP-1 mRNA (X400; 1). E and F. Tubular cells expressing MCP-1 mRNA surrounded by CD68 positive cells (X200; fl
expression was observed in IgA nephropathy [25]. Although the
present findings seem to be contradictory, we should recall that
cryoglobulinemic membranoproliferative GN is characterized by a
massive glomerular and interstitial monocyte infiltration, whereas
in other forms of GN the monocyte infiltrate is mainly localized in
the interstitium [21.
Our data, therefore, suggest that the deposition of ciyoglobu-
lins at renal level may cause the monocyte/macrophage influx
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Fig. 4. Immunohistochemistiy staining for MCP-
] protein. Positive staining for MCP-1 protein is
found in the glomerulus (A, X200; t) in the
interstitial areas with cellular infiltrates and in
tubular cells (B, X200; fl. C. A negative
control obtained with a non-immune mouse
serum (xlOO).
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A B C
Fig. 5. Northern blot analysis of total RNA from human mesangial cells
hybridized with a cDNA probe for MCP-I (upper panel). Mesangial cells
were incubated for six hours with serum free medium only (A), serum free
medium containing 100 jLg/ml of aggregated human lgG (B), and serum
free medium containing 100 pg/mI of human cryoglobulins (C) prior to the
RNA extraction. Lower panel shows the 18 s and 28 s bands of the blotted
membrane to demostrate equal loading in the three different lanes
(representative of three experiments).
through an induction of MCP-1 expression by resident cells, in
addition, since monocytes themselves produce the chemokine,
once these cells reach the mesangial or the interstitial areas, they
could generate a positive loop maintaining the inflammatory
process. Therefore, MCP-1 may represent the missing link be-
tween cryogiobulin deposition and monocyte-macrophage influx
in cryoglobulinemic GN. Once recruited in the glomerulus or in
the interstitial space monocytes may play a key role in the
pathogenesis of glomerular as well as tubulointerstitial lesions.
These cells may be a source and/or a reservoir of cytokines and
growth factor promoting and/or mantaining the activation of
resident cells [3, 26]. On the other hand, activated monocytes can
release reactive oxygen species and lysosomal enzymes causing
GBM and TBM proteolysis as well as glomerular and tubular
epithelial cell damage [26]. To support the hypothesis of a central
role for monocytes in the pathogenesis of renal damage there are
several observations in human and experimental GN correlating
the presence of these immune-activated cells with the histological
lesions and with clinical parameters, such as serum creatinine and
proteinuria [2, 27—30]. In particular, in cryoglobulinemic GN, the
degree of monocyte infiltration significantly correlates with the
amount of proteinuria [2]. Hence, the identification of chemoat-
tractant substances that are responsible for the recruitment of
macrophages at the renal level could help to develop target
therapies able to reduce the progression of renal damage. In this
perspective, MCP-1 could represent an easy target to reach.
Indeed, Mukaida et al demonstrated that dexametasone is able to
induce a down-regulation of MCP-1 mRNA expression induced
not available. However, we have recently observed that in acute
renal rejection, where an increased urinary MCP-1 concentration
was found, corticosteroid treatment was able to reduce urinary
MCP-1 concentration [33].
Acknowledgments
This study was partly supported by the APSNT (Associazione per il
Progresso Scientifico in Nefrologia e Trapianto), the Extramural Program
Grant Baxter (eighth round, 1995 to 1998), the Consiglio Nazionale delle
Ricerche (C.N.R.) Target Project on Biotechnology and Bioinstrumenta-
tion (93.1102.70) and the C.N.R. Joint Program USA-Italy (94.2336.04,
95.942.04), and by grants 40% (94.691) and 60% (93.4048, 94.6043
95.3957) from the Ministero dell' Universith c della Ricerca Scientifica e
Tecnologica. We acknowledge the technical help of Miss Annalisa
Brunaccini, Miss Carmela Marseglia and Miss Rita De Leonardis. We
thank Dr. G. Giannico for collecting clinical data and Dr. A.J. Valente for
providing the anti-MCP-i antibody.
Reprint requests to Prof F.P.Schena, Institute of Nephrology, University of
Bad, Polyclinic, Piazza Giulio Cesare, 11, 70124 Bad, Italy.
E-mail: kidney@teseo.it
References
1. BEN-BASSAT M, BONER G, ROSENFELD J, PICK A, KAHANA M, HAZART
B, HOCHMAN B: The clinieopathologic features of cryoglobulinemic
nephropathy. Am J Clin Pathol 79:147—156, 1983
2. FERRARIO F, CASTIGLIONE A, COLASANTI G, BARBIANO DI BELGioloso
G, BERTOLI 5, D'AMIco G: The detection of monocytes in human
glomerulonephritis. Kidney mt 28:513—519, 1985
3. VAN Gooa H, DING G, KEES-FOLTS D, GROND J, SCHREINER GF,
DIAMOND JR: Macrophages and renal disease. Lab In vest 71:456—464,
1994
4. Hoo DH, GEE DC, ATKINS RC: Leukocyte analysis using mono-
clonal antibodies in human glomerulonephritis. Kidney mt 31:964—
972, 1987
5. GOMEZ-CHIARRI M, ORTIZ A, SERON D, GONZALEZ E, EGIDO J: The
intercrine superfamily and renal diseases. Kidney mt 43(Suppl 39):
S81—S85, 1993
6. LEONARD EJ, YOSHIMURA T: Human monocyte chemoattractant
protein-i (MCP-1). Immunol Today 11:97—101, 1993
7. Yu X, DLUZ S, GRAVES DT, ZHANG L, ANTONIADES HN, HOLLANDER
W, PRUSTY S, VALENTE AJ, SCHwARZ CJ, SONENSHEIN GE: Elevated
expression of monocyte chemoattractant protein 1 by vascular smooth
muscle cells in hypercholesterolemic primates. Proc Nat! Acad SeE
USA 89:6953—6957, 1992
8. NELKEN NA, COUGHLIN SR, GORDON D, WILcox JN: Monocyte
chemoattractant protein-I in human atheromatous plaques. J Clin
Invest 88:1121—1127, 1991
by IL-I and TNF-a [31], and recently Noris et al showed that
corticosteroid therapy can reduce MCP-i urinary excretion in
lupus nephritis [32]. Interestingly, corticosteroids in association
with immunosuppressive agents and ACE inhibitors were able to
— MCP-1 reduce the amount of proteinuria in our patients (Table 1).
Unfortunately, in our study, post-treatment urinary samples were
In conclusion, our study demonstrates in vivo an increased
28 S MCP-1 gene and protein expression in human cryoglobulinemic
membranoproliferative GN. The strong correlation found be-
tween monocyte/macrophage infiltration and MCP-1 expression,
the reduction of proteinuria obtained with corticosteroids and the
previous investigations documenting in vivo expression of MCP-1
in other forms of experimental and human GN strongly support
the hypothesis of MCP-1 involvement in the pathogenesis of
18 monocyte/macrophage-induced renal damage. A prospectiveS study with a double renal biopsy using agents, such as corticoste-
roids, able to block MCP-1 activity in vivo is now warranted to
confirm this hypothesis.
Gesualdo ci a!: MCP-1 in ciyoglobulinemic GN 163
9. KOCH AE, KUNKEL SL, HARLOW LA, JOHNSON B, EVANOFF HL,
HAINES GK: Enhanced production of monocyte chemoattractant
protein-I in rheumatoid arthritis. J Clin Invest 90:772—779, 1992
10. ANTONIADES HN, NEVILLE-GOLDEN J, Govouios T, KRAD!N
RL, VALENTE AJ, GRAVES DT: Expression of monocyte chemoattrac-
tant protein-I in human idiopathic pulmonary fibrosis. Proc NatlAcad
Scj USA 89:5371—5375, 1992
11. RoviN BH, YOSHIMURA T, TAN L: Cytokine-induced production of
monocyte chemoattractant protein-i by cultured human mesangial
cells. J Immunol 148:2148—2153, 1992
12. SATRIANO JA, HORA K, SHAN Z, STANLEY ER, MORI T, SCHLONDORFF
D: Regulation of monocyte chemoattractant protein-i and macro-
phage colony-stimulating factor-I by 1FN y, tumor necrosis factor-n
IgG aggregates, and cAMP in mouse mesangial cells. J Immunol
150:1971—1978, 1993
13. ROLLINS BJ, YOSHIMURA T, LEONARD EJ, POBER JS: cytokine-
activated human endothelial cells synthesize and secrete a m000cyte
chemuattractant, MCP-i/JE. Am J Pathol 136:1229—1233, 1990
14. SCHMOUDER RL, STRIETER RM, KUNKEL SL: Interferon y regulation
of human cortical epithelial cell-derived monocyte chemotactic pep-
tide-i. Kidney mt 44:43—49, 1993
15. VALENTE AJ, GRAVES DT, VIALLE-VALENTIN CE, DELGADO R,
SCHWARZ CJ: Purification of a monocyte chemotactic factor secreted
by non human primate vascular cells in culture. Biochemistry 27:4162—
4167, 1988
16. COLOTTA F, BORRE A, WANG JM, TAT-TANELL! M, MADDALENA F,
POLENTARUTTI N, PER! G, MANTOVANI A: Expression of a monocyte
chemotactic cytokine by human mononuclear cells. J Immunol 148:
760—765, 1992
17. HORA K, SATRIANO JA, SANTIAGO A, MORI T, STANLEY ER, SHAN Z,
SCI!LONDORF D: Receptors for IgG complexes activate synthesis of
monocyte chemoattractant peptide 1 and colony-stimulating factor 1.
Proc NatlAcad Sci USA 89:1745—1749, 1992
18. ROVIN B, RUMANCIK M, TAN L, DICKERSON J: Glomerular expression
of Monocyte chemoattractant protein I in experimental and human
glomerulonephritis. Lab Invest 71:536—542, 1994
19. GESUAI.DO L, DI PAOLO S, MILAN! 5, PINzANI M, GRAPPONI C,
RANIER! E, PANNARALE G, SCHENA FP: Expression of Platelet-derived
growth factor receptors in normal and diseased human kidney. J Clin
Invest 94:50—58, 1994
20. GESUALDO L, Di PAOLO 5, RANIER! E, SCIIENA FP: Trapidil inhibits
human mesangial cells proliferation: Effect on PDGF a-receptor
binding and expression. Kidney lot 46:1002—1009, 1994
21. ROLLINS BJ, WALZ A, BAGGI0LINI M: Recombinant human MCP-
1/JE induces chemotaxis, calcium flux, and the respiratory burst in
human monocytes. Blood 78:1112—1116, 1991
22. JIANG Y, BELLER DI, FRENDL G, GRAVES DT: Monocyte chemoat-
tractant protein-I regulates adhesion molecule expression and cyto-
kine production in human monocytes.Jlmmunol 148:2423—2428, 1992
23. STAHL RA: Chemoattractants cytokines (chemokines) and immune
renal injury. Nephrol Dial Transplant 10:307-309, 1995
24. PRODJOSUDIADI W, GERRITSMA JSJ, VAN Es LA, DAHA MR, BRUIJN
JA: Monocyte chemoattractant protein-I in normal and diseased
human kidneys: An immunohistochemical analysis. Clin Nephrol
44:148—155, 1995
25. GRANDALIANO G, GESUALDO L, RANIER! E, MONNO R, MONTINARO
V, MARRA F, SCHENA FP: Monocyte chemotactic peptide-1 expression
in acute and chronic human nephritides: A pathogenetic role in
interstitial monocytes recruitment. JAm Soc Nephrol 7:906—913, 1996
26. NATHAN CF: Secretory products of macrophages. J Clin Invest 79:319—
326, 1987
27. RISDON RA, SLOPER JC, DEWARDENER HE: Relationship between
renal function and histological changes found in renal biopsy speci-
mens from patients with persistent glomerular nephritis. Lancet
1:363—366, 1968
28. SCHAINUK LI, STRIKER GE, CUTLER RE, BENDITF EP: Structural-
functional correlations in renal disease. Part II: The correlations. Hum
Pathol 1:631—640, 1970
29. DIAMOND JR, PESEK-DIAMON!) I: Sublethal X-irradiation during acute
puromycin nephrosis prevents late renal injury: Role of macrophages.
Am J Physiol 260:F779—F786, 1991
30. SArro T, ATKINS RC: Contributions of mononuclear leukocytes to the
progression of experimental focal glomerular sclerosis. Kidney Int
37:1076—1083, 1990
31. MUKAIDA N, ZACHARIAE CCO, GUSEL!.A GL, MATSUSHIMA K: Dexa-
methasone inhibits the induction of m000cyte chemotactic activating
factor production by IL-i or tumor necrosis factor. J Immunol
146:1212—1215, 1991
32. N0RIs M, BERNASCONI S, CASIRAGH! F, GorrI E, SozzAN! 5, MAN-
TOVAN! A, REMUZZI G: Monocyte chemoattractant-I (MCP-1) in
lupus nephritis. (abstract) JAm Soc Nephrol 6:846, 1995
33. GRANDALIANO G, GESUALDO L, RANIER! E, MONNO R, STALLONE G,
SCHENA FP: Monocyte chemotactic peptidc-I expression and mono-
cytes infiltration in acute renal transplant rejection. JAm Soc Nephrol
7:1885, 1996
